Spinal nerve defects in mouse embryos prenatally exposed to valproic acid
- 22 August 2016
- journal article
- research article
- Published by Springer Nature in Anatomical Science International
- Vol. 93 (1) , 35-41
Abstract
To examine in detail spinal nerve defects induced by prenatal exposure to valproic acid in mice, pregnant ICR mice were subcutaneously injected with a single dose of 400 mg/kg valproic acid on gestational day 6, 7, 8, or 9, and their embryos were observed on gestational day 10. The whole-mount immunostaining using an anti-neurofilament antibody allowed us to identify spinal nerve defects, such as a loss of bundle, anastomosis among bundles arising from adjacent segment, and a disrupted segmental pattern of the dorsal root ganglia, in valproic acid-exposed embryos. The prevalence of spinal nerve defects was the highest in the embryos exposed to valproic acid on gestational day 8 among the experimental groups. Then, effects of the administration dose of valproic acid on the prevalence of spinal nerve defects were examined on gestational day 10 and found to be dose-dependently increased. It was noteworthy that all embryos exposed to 600 mg/kg of valproic acid on gestational day 8 suffered spinal nerve defects. Folic acid (3 mg/kg/day) supplementation during gestational day 6–10 suppressed the prevalence of valproic acid-induced neural tube defects, which are common malformations in offspring prenatally exposed to valproic acid, but not that of spinal nerve defects. Thus, the spinal nerve defects due to prenatal valproic acid exposure might be induced by mechanisms different from those of neural tube defects. Because spinal nerve defects were predicted to be caused by the disrupted segmental arrangement of the somites and/or that of neural crest cells, which was the origin of the dorsal root ganglia and/or abnormal polarity of the somite, this mouse model with spinal nerve defects at high incidence would be useful to examine the effects of valproic acid on the somitogenesis and morphogenesis of somite-associated structures.Keywords
Funding Information
- Japan Society for the Promotion of Science (23591595, 26461634)
This publication has 30 references indexed in Scilit:
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood AutismJAMA, 2013
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyThe Lancet Neurology, 2013
- Animal model of autism induced by prenatal exposure to valproate: Behavioral changes and liver parametersBrain Research, 2011
- Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acidNeuroscience, 2010
- Valproic acid in pregnancy: How much are we endangering the embryo and fetus?Reproductive Toxicology, 2009
- Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentationDevelopment, 2009
- Segmental patterning of the vertebrate embryonic axisNature Reviews Genetics, 2008
- A clock and wavefront mechanism for somite formationDevelopmental Biology, 2006
- Cranial nerves and ganglia are altered after in vitro treatment of mouse embryos with valproic acid (VPA) and 4-en-VPADevelopmental Brain Research, 1996
- A clock and wavefront model for control of the number of repeated structures during animal morphogenesisJournal of Theoretical Biology, 1976